Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular diagnostic tests in hematologic diseases].

S Tohda1, N Nara

  • 1Laboratory Medicine, Graduate School, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|April 20, 2001
PubMed
Summary

Molecular diagnostic tests are crucial for hematologic malignancies like leukemia and lymphoma. This review covers current applications, limitations, and emerging technologies for these essential tests.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of the MYD88 mutation by the combination of the allele-specific PCR and quenching probe methods.

International journal of laboratory hematology·2017
Same author

Prognostic implications of blast self-renewal capacity in acute myelocytic-leukemia.

International journal of oncology·2011
Same author

The role of stroma cells on the proliferation and C-kit expression of acute myeloblastic-leukemia cells.

International journal of oncology·2011
Same author

The effects of retinoic Acid analogs on the blast cells of acute myeloblastic-leukemia in culture.

International journal of oncology·2011
Same author

Relation of protein kinase A and protein kinase C to signaling pathways of hematopoietic factors in leukemia cell lines.

International journal of oncology·2011
Same author

Phosphorylation of signaling proteins in factor-independent myeloid leukemia cell lines.

International journal of oncology·2011

Area of Science:

  • Molecular diagnostics
  • Hematologic malignancies
  • Cancer genomics

Context:

  • Molecular diagnostic tests are integral to managing hematologic malignancies, including leukemia and lymphoma.
  • Current methods include karyotyping, fluorescence in situ hybridization (FISH), Southern blot, and polymerase chain reaction (PCR).
  • Each technique has specific applications, requirements (e.g., dividing cells, skilled experts), and limitations (e.g., false positives, limited disease scope).

Purpose:

  • To review the current applications of molecular diagnostic tests in hematologic malignancies.
  • To discuss the inherent problems and limitations associated with these diagnostic methods.
  • To highlight emerging technologies poised for future clinical integration.

Summary:

  • Karyotyping is a standard diagnostic tool but requires dividing cells and expertise.
  • FISH analysis is used for monitoring treatment effects but has a false-positive rate.
  • PCR and reverse transcription (RT)-PCR offer high sensitivity for detecting specific gene fusions and minimal residual disease, with real-time and competitive PCR enabling quantitative analysis.

Impact:

  • Understanding the strengths and weaknesses of current molecular diagnostics informs clinical decision-making.
  • Identifies areas for improvement and guides the adoption of novel technologies.
  • Facilitates more accurate diagnosis, treatment monitoring, and prognostication in hematologic cancers.

Related Experiment Videos